Investments
5Portfolio Exits
1Funds
1Latest OMX Ventures News
Sep 28, 2021
Preclinical neuroscience company Delix Therapeutics, today announced the closing of a USD 70 million Series A financing round. The round was led by ARTIS Ventures, RA Capital Management, and founding investor OMX Ventures, with participation from a diverse syndicate of life sciences and psychedelic investment funds.
OMX Ventures Investments
5 Investments
OMX Ventures has made 5 investments. Their latest investment was in Mythic Therapeutics as part of their Series B on December 12, 2021.
OMX Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/15/2021 | Series B | Mythic Therapeutics | $103M | Yes | 3 | |
9/27/2021 | Series A | |||||
7/8/2021 | Seed VC | |||||
9/17/2020 | Series C | |||||
6/23/2020 | Series A - II |
Date | 12/15/2021 | 9/27/2021 | 7/8/2021 | 9/17/2020 | 6/23/2020 |
|---|---|---|---|---|---|
Round | Series B | Series A | Seed VC | Series C | Series A - II |
Company | Mythic Therapeutics | ||||
Amount | $103M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 3 |
OMX Ventures Portfolio Exits
1 Portfolio Exit
OMX Ventures has 1 portfolio exit. Their latest portfolio exit was Finch Therapeutics on March 19, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/19/2021 | IPO | 1 |
Date | 3/19/2021 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
OMX Ventures Fund History
1 Fund History
OMX Ventures has 1 fund, including OMX Ventures Fund I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
3/22/2021 | OMX Ventures Fund I | $150M | 2 |
Closing Date | 3/22/2021 |
|---|---|
Fund | OMX Ventures Fund I |
Fund Type | |
Status | |
Amount | $150M |
Sources | 2 |
OMX Ventures Team
2 Team Members
OMX Ventures has 2 team members, including current Managing Director, Craig Asher.
Name | Work History | Title | Status |
|---|---|---|---|
Craig Asher | Managing Director | Current | |
Daniel Fero | Merieux Equity Partners, and L.E.K. Consulting | Managing Director | Current |
Name | Craig Asher | Daniel Fero |
|---|---|---|
Work History | Merieux Equity Partners, and L.E.K. Consulting | |
Title | Managing Director | Managing Director |
Status | Current | Current |